Navigation Links
NOVAVAX Reports Third Quarter 2010 Financial Results
Date:11/5/2010

statements contained in this release.  Factors that may cause actual results to differ materially from the results discussed in the forward-looking statements or historical experience include, among other things, the following: our ability to progress any product candidates into pre-clinical or clinical trials; the scope, initiation, rate and progress of our pre-clinical studies and clinical trials and other research and development activities; clinical trial results; even with positive data from pre-clinical studies or clinical trials, the product candidate may not prove to be safe and efficacious; decisions by regulatory agencies may delay or prevent our development programs or increase the costs of such programs; regulatory approval is needed before any we can initiate clinical trials on our vaccines; regulatory approval is needed before any vaccines can be sold in or outside the United States and, to date, no governmental authority has approved any of our vaccine candidates for sale; influenza is seasonal in nature, and if approval or commercial launch after approval is not timely in relation to the influenza season, we may not be able to manufacture or sell our influenza vaccines on terms favorable to us until the next influenza season, if at all; RSV is a difficult disease to prevent and there is significant activity by many companies toward the development of a suitable vaccine; we have not manufactured any of our vaccine candidates at a commercial level; we utilize a unique manufacturing process and the scale-up of that process may prove difficult and/or costly; our dependence on third parties to manufacture and distribute our vaccines; risks associated with conducting business outside of the United States; the cost and our ability of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights; competition for clinical resources and patient enrollment from drug candidates in developm
'/>"/>

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Novavax to Report Third Quarter 2010 Financial Results on November 5, 2010
2. NOVAVAX to Present at BIO Investor Forum
3. NOVAVAX to Present at Stifel Nicolaus Conference
4. NOVAVAX Endorses New U.S. Initiatives to Develop Medical Countermeasures
5. NOVAVAX Announces Issuance of Key U.S. Patent for Influenza Virus-Like Particle (VLP) Vaccines
6. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
7. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
8. NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results
9. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
10. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
11. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , September 17, 2014 According ... by Component (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU), ... & Wellness), and by Geography - Global Forecast to ... electronics market is expected to reach $56.50 Billion by ... to 2020. Browse 235 market data Tables ...
(Date:9/17/2014)... -- Women everywhere know how frustrating a vaginal infection ... often also embarrassing and have a way of derailing ... http://ph-defense.com ) is a new, over-the-counter product designed to ... Odor, discharge, and discomfort or itch ... many cases, the cause of such problems can be ...
(Date:9/17/2014)... LEIPZIG, Germany , Sept. 17, ... has entered into an exclusive technology development partnership ... imaging agents to image CD4+ positive immune T ... ImaginAb,s capability to precisely diagnose and determine therapeutic ... areas. The ability to image CD4+ T-cells will ...
Breaking Medicine Technology:Medical Electronics Market Worth $56.50 Billion by 2020 2Medical Electronics Market Worth $56.50 Billion by 2020 3Medical Electronics Market Worth $56.50 Billion by 2020 4New Product from Vireo Systems: pH-D Feminine Health Support 2ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell Imaging 2
... , , , ... service Contract Research Organization (CRO) founded in India, today announced the ... Application Suite (OLSAS) by going live with Oracle Siebel Clinical Trial ... , "We are excited to have the rollout of ...
... Aug. 5 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: ... a New Drug Submission (NDS) with the Therapeutic Products ... the antidepressant trazodone. , "We are pleased to file ... R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. ...
Cached Medicine Technology:SIRO Clinpharm Completes Successful Implementation of Oracle Life Sciences Application Suite 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 2Labopharm files New Drug Submission with Health Canada for novel antidepressant 3
(Date:9/18/2014)... 2014 First Choice Emergency Room ... in the United States, named Douglas J. Harrison, DO ... facility. , “We are pleased to welcome Dr. ... of our new Missouri City-Lakes facility,” said Dr. James ... Room. , Dr. Harrison received his undergraduate degree ...
(Date:9/18/2014)... N-Zyme Scientifics LLC achieved a major developmental milestone ... mere 8 months after company startup. Its novel product ... enzyme used in the “Biologics” industry for discovery and ... pathology on Mass Spec devices. PRIME™ is being sold ... market (PNGase F PRIMETM). N-Zyme is currently evaluating ...
(Date:9/17/2014)... Recently, BambooIndustry.com, an outstanding company in the bamboo industry, ... There are more than 1000 items in this range. To ... for these useful items. Each of them is now offered ... “We are very proud to unveil the new range of ... are made with natural materials by experienced workers. They are ...
(Date:9/17/2014)... Recently, UWDress.com, an innovative company that ... occasion outfits, has released its 2014 empire waist ... has launched a big sale for these new and ... deeply discounted rates, from 15 to 65 percent off. ... on using comfortable to wear materials. Its elegant items ...
(Date:9/17/2014)... (PRWEB) September 18, 2014 Dr. Shalev is ... came to Houston to study at the University of Texas, ... While studying she realized her real passion lay in dentistry, ... Surgery from the University of Texas Health Science Center at ... dentistry, and is a member of The Greater Houston Dental ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Douglas J. Harrison as Medical Director of Missouri City - Lakes, Texas Facility 2Health News:N-Zyme Scientifics Announces Successful Product Launch 2Health News:More Than 1000 Items Added To BambooIndustry.com’s Bamboo Flooring Collection 2Health News:2014 Empire Waist Evening Dress Collection Now Unveiled At UWDress.com 2
... to New York City officials, many are blind to the ... the public about the use of such eye makeup products ... Asia, Middle East and North Africa. These products used traditionally ... above 50 percent lead, a known toxin. ...
... factors accurately predicts which patients being considered for gastric bypass ... ,The scoring system, which was first proposed last year by ... new study of more than 4,400 patients. The system takes ... risk of developing a blood clot in the lungs. ...
... active older adults infected with HIV has unprotected sex, according ... 260 HIV-positive older adults found that of those having sex, ... ,AIDs cases among the over-50 crowd reached 90,000 ... Prevention, they will account for half of all HIV/AIDS cases ...
... depression in women, according to researchers at the University ... published in a recent issue of Preventive Medicine found ... in women. In addition, self-weighing daily, rather than once ... Mass Index (BMI) levels in women 40 years or ...
... least 3 years after undergoing in vitro fertilization (IVF) ... cell// research, according to a report. ,The ... of the report, was the complete and clear explanation ... legal advisor and embryologist, which helped couples navigate the ...
... were granted early retirement in the past three years, even ... was informed Thursday. ,Of those who retired early, ... and 37,865 were personnel below officer rank (PBOR) for a ... hour in the Lok Sabha. ,Giving the break ...
Cached Medicine News:Health News:Simple System Accurately Predicts Weight-loss Surgery Risk 2Health News:Simple System Accurately Predicts Weight-loss Surgery Risk 3Health News:One-Third of Sexually Active Older Adults With HIV/AIDs Has Unprotected Sex 2Health News:Many Couples Choose to Donate Surplus Embryos for Stem Cell Research 2Health News:Numerous Defense Personnel Granted Early Retirement Due to Mental Illness 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: